FDA alleges 'manipulated' data supported approval of Amgen’s autoimmune drug

The FDA has renewed calls for Amgen’s Tavneos to be pulled from the market, saying it has discovered new evidence that study personnel doctored the results of the drug’s pivotal study in order to make it look effective.